Literature DB >> 8875206

Animal models for the preneoplastic lesions of the prostate.

L Pylkkänen1, S Mäkelä, R Santti.   

Abstract

OBJECTIVES: Reliable and adequate animal models are required, not only for investigation of etiology, pathogenesis, and treatment of prostate cancer, but also for chemoprevention of prostatic carcinogenesis.
METHODS: Animal models for the study of premalignant changes in the prostate are reviewed in the paper, with specific reference to the neonatally estrogenized mouse model.
RESULTS: Neonatal treatment of newborn Han:NMRI mice with synthetic non-steroidal estrogen, diethylstilbestrol (DES; 2 micrograms/pup on days 1-3 after birth) promoted hyperplastic and dysplastic changes in the periurethral region of the prostate at the age of 9-18 months. Dietary soy partially inhibited the development of prostatic dysplasia in these neonatally estrogenized animals, which may be due to phytoestrogens contained in soy-rich food.
CONCLUSION: Prostatic cancer and its possible precursors develop spontaneously, or can be induced by different chemical and hormonal manipulations in certain animal species and strains. Neonatal estrogenization of the mouse results in prostatic dysplasia, which can be partially prevented by dietary soy. There are morphological similarities between human prostatic intraepithelial neoplasia (PIN) and dysplastic changes in rodent prostates, but more data is needed before these dysplastic lesions can be considered equivalent to human PIN.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8875206     DOI: 10.1159/000474175

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  6 in total

1.  Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma.

Authors:  I Leav; K M Lau; J Y Adams; J E McNeal; M E Taplin; J Wang; H Singh; S M Ho
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  A role for estrogen receptor beta in the regulation of growth of the ventral prostate.

Authors:  Z Weihua; S Makela; L C Andersson; S Salmi; S Saji; J I Webster; E V Jensen; S Nilsson; M Warner; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

3.  Estrogen receptor expression in prostate cancer and premalignant prostatic lesions.

Authors:  H Bonkhoff; T Fixemer; I Hunsicker; K Remberger
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

Review 4.  Estrogenic environmental chemicals and drugs: mechanisms for effects on the developing male urogenital system.

Authors:  Julia A Taylor; Catherine A Richter; Rachel L Ruhlen; Frederick S vom Saal
Journal:  J Steroid Biochem Mol Biol       Date:  2011-07-30       Impact factor: 4.292

5.  Estrogen receptor beta expression in prostate adenocarcinoma.

Authors:  Mojgan Asgari; Arman Morakabati
Journal:  Diagn Pathol       Date:  2011-07-06       Impact factor: 2.644

6.  In Vivo Study of the Effects of ERβ on Apoptosis and Proliferation of Hormone-Independent Prostate Cancer Cell Lines PC-3M.

Authors:  Changli Zhou; Chunyu Yu; Lirong Guo; Xige Wang; Huimin Li; Qinqin Cao; Feng Li
Journal:  Biomed Res Int       Date:  2018-06-19       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.